CD32‐Mediated Platelet Aggregation In Vitro by Anti‐Thymocyte Globulin: Implication of Therapy‐Induced In Vivo Thrombocytopenia
暂无分享,去创建一个
E. Bielek | G. Boltz‐Nitulescu | C. Buchta | B. Moser | A. Zuckermann | E. Wolner | H. Ankersmit | G. Roth | E. Jensen‐Jarolim | W. Schmid | I. Volf | M. Brunner | C. Rosin
[1] P. Nurden,et al. Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. , 2002, Blood.
[2] G. Boltz‐Nitulescu,et al. Activation‐induced T cell death, and aberrant T cell activation via TNFR1 and CD95‐CD95 ligand pathway in stable cardiac transplant recipients , 2002, Clinical and experimental immunology.
[3] R. Kroczek,et al. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. , 2001, Blood.
[4] J. Revillard,et al. A quantitative flow cytometry assay for the preclinical testing and pharmacological monitoring of rabbit antilymphocyte globulins (rATG). , 2000, Journal of immunological methods.
[5] M. Czerny,et al. Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulines. , 2000, Transplantation.
[6] D. Mancini,et al. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. , 2000, The New England journal of medicine.
[7] Scott M. Taylor,et al. The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model. , 1999, Journal of immunology.
[8] M. Aiach,et al. Role of FCγRIIA Gene Polymorphism in Human Platelet Activation by Monoclonal Antibodies , 1995, Thrombosis and Haemostasis.
[9] M. Mihatsch,et al. A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT3 after renal transplantation. , 1995, Transplantation.
[10] J. Thomas,et al. A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. , 1994, Transplantation.
[11] R. Carroll,et al. Interaction of two GPIIb/IIIa monoclonal antibodies with platelet Fc receptor (FcγRII) , 1991 .
[12] C. Vincent,et al. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. , 1991, Transplantation.
[13] A. Andrieux,et al. Identification of a monoclonal antibody against platelet GPIIb that interacts with a calcium-binding site and induces aggregation. , 1990, The Journal of biological chemistry.
[14] R. Carroll,et al. Platelet activation by CD9 monoclonal antibodies is mediated by the FCγII receptor , 1990 .
[15] A. Bacigalupo,et al. Long‐term follow‐up of severe aplastic anaemia patients treated with antithymocyte globulin , 1989 .
[16] A. Levey,et al. Life-threatening thrombocytopenia complicating antithymocyte globulin therapy for acute kidney transplant rejection. Evidence of in situ immune complex formation on the platelet surface. , 1988, Transplantation.
[17] L. Chatenoud,et al. ONE‐MONTH PROPHYLACTIC USE OF OKT3 IN CADAVER KIDNEY TRANSPLANT RECIPIENTS , 1988, Transplantation.
[18] N. Young,et al. Biological and immunological characterization of ATG and ALG. , 1986, Blood.
[19] L. Jennings,et al. Monoclonal antibodies to human platelet glycoprotein IIb beta that initiate distinct platelet responses. , 1985, Blood.
[20] A. Nienhuis,et al. Antithymocyte globulin reacts with many normal human cell types. , 1983, Blood.
[21] J. Bennett,et al. Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets. , 1983, The Journal of biological chemistry.
[22] J. Hoxie,et al. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[23] A. Novick,et al. A CONTROLLED RANDOMIZED DOUBLE‐BLIND STUDY OF ANTILYMPHOBLAST GLOBULIN IN CADAVER RENAL TRANSPLANTATION , 1983, Transplantation.
[24] A. Matas,et al. Seven Years' Experience with Antilymphoblast Globulin for Renal Transplantation From Cadaver Donors , 1976, Annals of surgery.
[25] Najarian Js,et al. Platelet activity of antilymphocyte serum (ALS) preparations. , 1973 .
[26] R. Carroll,et al. Interaction of two GPIIb/IIIa monoclonal antibodies with platelet Fc receptor (Fc gamma RII). , 1991, British journal of haematology.
[27] R. Carroll,et al. Platelet activation by CD9 monoclonal antibodies is mediated by the Fc gamma II receptor. , 1990, British journal of haematology.
[28] A. Bacigalupo,et al. Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT). , 1989, British journal of haematology.